GS 2: International RelationsGS 3: Internal SecurityPrelims
India to host BRICS anti-drugs meet today, Pg12
India hosts BRICS anti-drug agencies meet in Guwahati, aiming for action-oriented collaboration against synthetic drugs and enhanced intelligence sharing.
India is hosting the two-day BRICS Heads of Anti-Drug Agencies meeting in Guwahati from July 6-7, 2026.
The meeting is organized by the Narcotics Control Bureau (NCB) under the Union Home Ministry.
Key objectives include combating synthetic drugs, strengthening intelligence sharing, and enhancing operational coordination among BRICS nations.
India holds the BRICS Chairmanship in 2026, guiding the theme "Building for Resilience, Innovation, Cooperation and Sustainability".
Detailed Insights:
The meeting aims to transition BRICS cooperation from dialogue-centric engagement to structured and action-oriented collaboration in drug control.
Discussions will focus on information sharing regarding clandestine laboratories, emerging synthetic drug trends, and enhanced monitoring of precursor chemicals.
Other areas of cooperation include intelligence exchange, sharing of best practices, joint training programs, and expert exchanges.
The meeting is expected to conclude with the adoption of a joint declaration to reinforce collective action against transnational drug threats.
India will use this platform to highlight its intensified efforts against drug trafficking and substance abuse, including enforcement, awareness, and treatment.
The expanded BRICS grouping comprises 11 member countries: Brazil, China, Egypt, Ethiopia, India, Indonesia, Iran, Russia, Saudi Arabia, South Africa, and the United Arab Emirates.
Key Concepts Involved:
BRICS: An intergovernmental organization of 11 major emerging economies, serving as a platform for political, economic, and social cooperation.
Narcotics Control Bureau (NCB): India's federal law enforcement and intelligence agency under the Ministry of Home Affairs, tasked with combating drug trafficking and abuse under the Narcotic Drugs and Psychotropic Substances Act, 1985.
Synthetic Drugs: Substances artificially created in laboratories to mimic the effects of illicit drugs, often posing challenges due to rapid chemical modification and difficulty in detection.
Precursor Chemicals: Substances essential for the manufacture of illicit drugs, many of which also have legitimate industrial and commercial uses, requiring strict monitoring to prevent diversion.